KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $63.0 million.

  • Organon's Change in Inventory rose 327.87% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.0 million, marking a year-over-year decrease of 3523.32%. This contributed to the annual value of $131.0 million for FY2024, which is 4304.35% down from last year.
  • According to the latest figures from Q3 2025, Organon's Change in Inventory is $63.0 million, which was up 327.87% from $34.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Change in Inventory ranged from a high of $95.0 million in Q2 2022 and a low of -$35.0 million during Q2 2021
  • Over the past 5 years, Organon's median Change in Inventory value was $48.0 million (recorded in 2021), while the average stood at $42.8 million.
  • Over the last 5 years, Organon's Change in Inventory had its largest YoY gain of 39677.42% in 2021, and its largest YoY loss of 27500.0% in 2021.
  • Organon's Change in Inventory (Quarter) stood at $48.0 million in 2021, then surged by 79.17% to $86.0 million in 2022, then increased by 8.14% to $93.0 million in 2023, then plummeted by 66.67% to $31.0 million in 2024, then surged by 103.23% to $63.0 million in 2025.
  • Its Change in Inventory was $63.0 million in Q3 2025, compared to $34.0 million in Q2 2025 and -$3.0 million in Q1 2025.